William M. McClements, SVP of Corporate Operations at MERRIMACK PHARMACEUTICALS INC (MACK), bought 2,000 shares at $4.06 ($8K) on 2013-12-02, disclosed to the SEC on 2013-12-04.
Open-market purchase of $8k MACK by SVP of Corporate Operations. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| Filing → |
| MACK | BUY | 2013-12-02 | $25K | — | Filing → |